These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36765615)

  • 1. Novel Computed-Tomography-Based Transformer Models for the Noninvasive Prediction of PD-1 in Pre-Operative Settings.
    Wei Y; Yang M; Xu L; Liu M; Zhang F; Xie T; Cheng X; Wang X; Che F; Li Q; Xu Q; Huang Z; Liu M
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT-based transformer model for non-invasively predicting the Fuhrman nuclear grade of clear cell renal cell carcinoma.
    Yang M; He X; Xu L; Liu M; Deng J; Cheng X; Wei Y; Li Q; Wan S; Zhang F; Wu L; Wang X; Song B; Liu M
    Front Oncol; 2022; 12():961779. PubMed ID: 36249050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence risk stratification for locally advanced cervical cancer using multi-modality transformer network.
    Wang J; Mao Y; Gao X; Zhang Y
    Front Oncol; 2023; 13():1100087. PubMed ID: 36874136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep learning radiomics based on contrast enhanced computed tomography predicts microvascular invasion and survival outcome in early stage hepatocellular carcinoma.
    Yang Y; Zhou Y; Zhou C; Ma X
    Eur J Surg Oncol; 2022 May; 48(5):1068-1077. PubMed ID: 34862094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-supervised contrastive learning using CT images for PD-1/PD-L1 expression prediction in hepatocellular carcinoma.
    Xie T; Wei Y; Xu L; Li Q; Che F; Xu Q; Cheng X; Liu M; Yang M; Wang X; Zhang F; Song B; Liu M
    Front Oncol; 2023; 13():1103521. PubMed ID: 36937385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early stage NSCLS patients' prognostic prediction with multi-information using transformer and graph neural network model.
    Lian J; Deng J; Hui ES; Koohi-Moghadam M; She Y; Chen C; Vardhanabhuti V
    Elife; 2022 Oct; 11():. PubMed ID: 36194194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.
    Zhang SW; Zhang NN; Zhu WW; Liu T; Lv JY; Jiang WT; Zhang YM; Song TQ; Zhang L; Xie Y; Zhou YH; Lu W
    Front Oncol; 2022; 12():946531. PubMed ID: 35936698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Role of Computed Tomography Texture Analysis in Patients with Metastatic Urothelial Cancer Treated with Programmed Death-1 and Programmed Death-ligand 1 Inhibitors.
    Alessandrino F; Gujrathi R; Nassar AH; Alzaghal A; Ravi A; McGregor B; Sonpavde G; Shinagare AB
    Eur Urol Oncol; 2020 Oct; 3(5):680-686. PubMed ID: 31412003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images.
    Tian P; He B; Mu W; Liu K; Liu L; Zeng H; Liu Y; Jiang L; Zhou P; Huang Z; Dong D; Li W
    Theranostics; 2021; 11(5):2098-2107. PubMed ID: 33500713
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of Increased Programmed Death Ligand 1 Expression and Regulatory T Cells Infiltration with Higher Hepatocellular Carcinoma Recurrence in Patients with Hepatitis B Virus Pre-S2 Mutant after Curative Surgical Resection.
    Jeng LB; Li TC; Hsu SC; Teng CF
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics analysis of ultrasound to predict recurrence of hepatocellular carcinoma after microwave ablation.
    Wu JP; Ding WZ; Wang YL; Liu S; Zhang XQ; Yang Q; Cai WJ; Yu XL; Liu FY; Kong D; Zhong H; Yu J; Liang P
    Int J Hyperthermia; 2022; 39(1):595-604. PubMed ID: 35435082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CT-derived deep neural network predicts for programmed death ligand-1 expression status in advanced lung adenocarcinomas.
    Zhu Y; Liu YL; Feng Y; Yang XY; Zhang J; Chang DD; Wu X; Tian X; Tang KJ; Xie CM; Guo YB; Feng ST; Ke ZF
    Ann Transl Med; 2020 Aug; 8(15):930. PubMed ID: 32953730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomic model to predict the expression of PD-1 and overall survival of patients with ovarian cancer.
    Gao L; Jiang W; Yue Q; Ye R; Li Y; Hong J; Zhang M
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109335. PubMed ID: 36279669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting PD-L1 expression status in patients with non-small cell lung cancer using [
    Zhao X; Zhao Y; Zhang J; Zhang Z; Liu L; Zhao X
    EJNMMI Res; 2023 Jan; 13(1):4. PubMed ID: 36682020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics-based prediction model for outcomes of PD-1/PD-L1 immunotherapy in metastatic urothelial carcinoma.
    Park KJ; Lee JL; Yoon SK; Heo C; Park BW; Kim JK
    Eur Radiol; 2020 Oct; 30(10):5392-5403. PubMed ID: 32394281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MVI-Mind: A Novel Deep-Learning Strategy Using Computed Tomography (CT)-Based Radiomics for End-to-End High Efficiency Prediction of Microvascular Invasion in Hepatocellular Carcinoma.
    Wang L; Wu M; Li R; Xu X; Zhu C; Feng X
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomic Analysis Based on Magnetic Resonance Imaging for Predicting PD-L2 Expression in Hepatocellular Carcinoma.
    Tao YY; Shi Y; Gong XQ; Li L; Li ZM; Yang L; Zhang XM
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
    Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
    J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.